Trial Profile
A Phase III, multi-center, randomized, double-blind, non-inferiority study of Solithromycin versus Cefcapene pivoxil hydrochloride hydrate in patients with sinusitis
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 11 Oct 2018
Price :
$35
*
At a glance
- Drugs Solithromycin (Primary) ; Cefcapene pivoxil
- Indications Sinusitis
- Focus Adverse reactions; Registrational; Therapeutic Use
- Sponsors Toyama Chemical
- 02 Oct 2018 Status changed from recruiting to completed.
- 24 Oct 2017 New trial record